David Zangen

David Zangen

Auto-generated profile, based on publicly available information

David Zangen

Division of Pediatric Endocrinology, Hadassah Hebrew University Medical Center, Jerusalem, Israel

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2011 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
DZDavid Zangen
David Zangen
YKYotam Kaufman
Yotam Kaufman
SZSharon Zeligson
Sharon Zeligson
SPShira Perlberg
Shira Perlberg
HFHila Fridman
Hila Fridman
ELEphrat Levy-Lahad
Ephrat Levy-Lahad

20 October 2015 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
AWAriella Weinberg-Shukron
Ariella Weinberg-Shukron
PRPaul Renbaum
Paul Renbaum
RKRachel Kalifa
Rachel Kalifa
SZSharon Zeligson
Sharon Zeligson
ZBZiva Ben-Neriah
Ziva Ben-Neriah
DZDavid Zangen
David Zangen
Ovarian development and maintenance are poorly understood; however, diseases that affect these processes can offer insights into the underlying mechanisms. XX female gonadal dysgenesis (XX-GD) is a rare, genetically heterogeneous disorder that is characterized by underdeveloped, dysfunctional ovaries, with subsequent lack of spontaneous pubertal development, primary amenorrhea, uterine hypoplasia, and hypergonadotropic hypogonadism. Here, we report an extended consanguineous family of Palestinian origin, in which 4 females exhibited XX-GD. Using homozygosity mapping and whole-exome sequencing, we identified a recessive missense mutation in nucleoporin-107 (NUP107, c.1339G>A, p.D447N). This mutation segregated with the XX-GD phenotype and was not present in available databases or in 150 healthy ethnically matched controls. NUP107 is a component of the nuclear pore complex, and the NUP107-associated protein SEH1 is required for oogenesis in Drosophila. In Drosophila, Nup107 knockdown in somatic gonadal cells resulted in female sterility, whereas males were fully fertile. Transgenic rescue of Drosophila females bearing the Nup107D364N mutation, which corresponds to the human NUP107 (p.D447N), resulted in almost complete sterility, with a marked reduction in progeny, morphologically aberrant eggshells, and disintegrating egg chambers, indicating defective oogenesis. These results indicate a pivotal role for NUP107 in ovarian development and suggest that nucleoporin defects may play a role in milder and more common conditions such as premature ovarian failure.

8 April 2014 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
DZDavid Zangen
David Zangen
YKYotam Kaufman
Yotam Kaufman
EBEhud Banne
Ehud Banne
AWAriella Weinberg-Shukron
Ariella Weinberg-Shukron
AAAbdulsalam Abulibdeh
Abdulsalam Abulibdeh
ELEphrat Levy-Lahad
Ephrat Levy-Lahad
The transcription factor steroidogenic factor 1 (SF-1; also known as NR5A1) is a crucial mediator of both steroidogenic and nonsteroidogenic tissue differentiation. Mutations within SF1 underlie different disorders of sexual development (DSD), including sex reversal, spermatogenic failure, ovarian insufficiency, and adrenocortical deficiency. Here, we identified a recessive mutation within SF1 that resulted in a substitution of arginine to glutamine at codon 103 (R103Q) in a child with both severe 46,XY-DSD and asplenia. The R103Q mutation decreased SF-1 transactivation of TLX1, a transcription factor that has been shown to be essential for murine spleen development. Additionally, the SF1 R103Q mutation impaired activation of steroidogenic genes, without affecting synergistic SF-1 and sex-determining region Y (SRY) coactivation of the testis development gene SOX9. Together, our data provide evidence that SF-1 is required for spleen development in humans via transactivation of TLX1 and that mutations that only impair steroidogenesis, without altering the SF1/SRY transactivation of SOX9, can lead to 46,XY-DSD.

1 May 2016 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
RTReuven Tsabari
Reuven Tsabari
HEHila Iron Elyashar
Hila Iron Elyashar
MCMalena Cohen Cymberknowh
Malena Cohen Cymberknowh
OBOded Breuer
Oded Breuer
SAShoshana Armoni
Shoshana Armoni
DZDavid Haim Zangen
David Haim Zangen

1 July 2008 in Diabetes
Verified
Journal Article
Open access
MAMaha Abdulhadi-Atwan
Maha Abdulhadi-Atwan
JBJeremy D. Bushman
Jeremy D. Bushman
STSharona Tornovsky-Babaey
Sharona Tornovsky-Babaey
APAvital Perry
Avital Perry
AAAbdulsalam Abu-Libdeh
Abdulsalam Abu-Libdeh
DZDavid H. Zangen
David H. Zangen
OBJECTIVE—Congenital hyperinsulinism, usually associated with severe neonatal hypoglycemia, may progress to diabetes, typically during the 4th decade of life in nonpancreatectomized patients. We aimed to genotype the ATP-sensitive K+ channel in a 10.5-year-old girl presenting with overt diabetes following hyperinsulinism in infancy. RESEARCH DESIGN AND METHODS—A female aged 10.5 years presented with new-onset, antibody-negative diabetes (A1C 10.6%). She was born large for gestational age (5 kg) to a nondiabetic mother and developed frequent hypoglycemic episodes, which persisted until age 3 years and responded initially to intravenous glucose and later to oral sweets. Currently, she is fully pubertal and obese (BMI 30.2 kg/m2), with a partially controlled convulsive disorder (since age 1 year) and poor school performance. Glucose levels were >11.1 mmol/l throughout 72 h of continuous glucose monitoring, with low insulin secretion during intravenous glucose tolerance testing. KCNJ11 and ABCC8 mutation analysis was performed, and the mutation identified was characterized in COSm6 cells. RESULTS—A novel, de novo heterozygous ABCC8 sulfonylurea receptor (SUR)1 mutation (R370S) was identified in the patient's DNA but not in that of either parent. Cotransfection of Kir6.2 and mutant SUR1 demonstrate that the mutated protein is expressed efficiently at the cell surface but fails to respond to MgADP, resulting in minimal channel activity. Interestingly, the heterozygous channel (WT:R370S) responded well to glibenclamide, a finding that lead to the successful initiation of sulfonylurea therapy. CONCLUSIONS—This new ABCC8 mutation is associated with neonatal hyperinsulinism progressing within 10 years to insulinopenic diabetes. Consistent with in vitro findings, the patient responded to sulfonylurea treatment. The mechanism causing the relatively rapid loss in β-cell function is not clear, but it may involve mutation-induced increased β-cell apoptosis related to increased metabolic demand.

1 February 2010 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
ALAbdulsalam Abu Libdeh
Abdulsalam Abu Libdeh
FLFloris Levy-Khademi
Floris Levy-Khademi
MAMaha Abdulhadi-Atwan
Maha Abdulhadi-Atwan
EBEmily Bosin
Emily Bosin
MKMira Korner
Mira Korner
DZDavid H Zangen
David H Zangen
Background: Familial neurohypophyseal diabetes insipidus (FNDI), usually an autosomal dominant disorder, is caused by mutations in the arginine vasopressin (AVP)–neurophysin II preprohormone leading to aberrant preprohormone processing and gradual destruction of AVP-secreting cells. Patients typically present between 1 and 6 years of age with polyuria and polydipsia.Objective: Clinical, biochemical, and genetic studies of three new cases of autosomal recessive FNDI presenting in early infancy.Patients: Three Palestinian cousins presented with failure to thrive, vomiting, irritability, and fever. The parents were asymptomatic. Patients developed hypernatremia (154–163 mmol/l) and serum hyperosmolality (>320 mOsm/kg), while urine osmolality remained between 73 and 229 mOsm/kg. Plasma AVP levels were low, and the posterior pituitary bright spot was absent on magnetic resonance imaging (MRI). All patients responded to desmopressin.Results: Patients were homozygous and parents were heterozygous for microsatellite markers flanking the AVP gene. All patients were homozygous for the P26L (proline to leucine) substitution affecting mature AVP. A founder effect with the single original kindred carrying the P26L mutation was confirmed by microsatellite analysis, but patients in that family presented only at 2 years of age. In microsatellite analysis, the new kindred patients were not homozygous and did not share a single allele at the aquaporin 2 and vasopressin receptor-2 genes locuses.Conclusion: This is the first description of autosomal recessive FNDI presenting in the neonatal period. The unusual early clinical and radiological (MRI) presentation argues against gradual destruction of AVP-secreting neurons as the pathophysiological mechanism. Factors beside allelism of AVP-related genes must influence the age of FNDI presentation given the founder effect demonstrated for the P26L mutation.